Note: This column describes the author’s own experiences with prednisone. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. What is a prednisone taper? Technically, it means to gradually lessen the dosage of the corticosteroid over time. But if…
After years spent journeying around the world, Ulysses, the main character in Homer’s epic “Odyssey,” reaches the safety of home. Changed by the stimulation of dangerous adventures, he finds the tranquility unbearable. Having passed from youth to old age, he decides to spend whatever time remains on a…
The use of an inactivated vaccine against SARS-CoV-2, the virus that causes COVID-19, is not linked to an increased risk of symptom worsening among people with myasthenia gravis (MG), according to a small study from China. “COVID-19 vaccination has no long-term impact on MG relapse,” researchers wrote. However, a…
People with myasthenia gravis (MG) who are positive for antibodies against the acetylcholine receptor (AChR) — the most common MG-causing antibodies — tend to have increased activation of part of the immune system called the complement cascade, according to a recent study. However, increased complement activation was not…
I failed at being a business owner. Big time. I had to lay off employees and break contracts, and I felt like I had let a lot of people down because of myasthenia gravis (MG). I’m still paying debts a year and a half after closing the business…
In 2020, a myasthenia gravis (MG) diagnosis completely changed my life. According to the Myasthenia Gravis Foundation of America, the prevalence of this disease in the U.S. is estimated at 14 to 20 per 100,000. That means there are about 36,000 to 60,000 cases. So why was I…
Vyvgart (efgartigimod alfa-fcab) is now approved in Israel for the treatment of generalized myasthenia gravis (gMG), according to its developer, Argenx. This is the second new approval for Vyvgart in gMG this year, following a similar positive decision in the U.K. in March. The therapy has…
Repeated treatment with under-the-skin efgartigimod had a consistent effect in easing symptoms of generalized myasthenia gravis (gMG), with no new safety issues identified. That’s according to interim data from the Phase 3 extension study ADAPT-SC+ (NCT04818671), which is…
“Would you stop sharing so much about mya … whatever the hell it is you have? All you’re doing is looking for attention.” Anyone else heard that before? Maybe from colleagues at work when you’re trying to explain why you’re requesting accommodations? Or family members who roll their eyes…
More generalized myasthenia gravis (gMG) patients who received Ultomiris (ravulizumab) in the Phase 3 CHAMPION MG trial achieved a favorable clinical response to treatment relative to those taking a placebo, according to new trial analyses. The proportion of patients achieving that milestone, according to the Myasthenia Gravis Foundation…
Get regular updates to your inbox.
